Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 9 , ISSUE 4 ( October-December, 2017 ) > List of Articles

ORIGINAL ARTICLE

Single Nucleotide Polymorphisms in CD14 and Toll-like Receptor 4 Genes in Patients with Polycystic Ovarian Syndrome

Roya Rozati, Nazima Allauddin

Citation Information : Rozati R, Allauddin N. Single Nucleotide Polymorphisms in CD14 and Toll-like Receptor 4 Genes in Patients with Polycystic Ovarian Syndrome. J South Asian Feder Obs Gynae 2017; 9 (4):304-307.

DOI: 10.5005/jp-journals-10006-1518

License: CC BY 3.0

Published Online: 01-01-2016

Copyright Statement:  Copyright © 2017; The Author(s).


Abstract

Introduction

Polycystic ovary syndrome (PCOS) is a complex disease having genetic, immunologic, and environmental components, and candidate genes on innate immunity have been hypothesized to be involved in its etiology. We examined the possible association of CD14 and toll-like receptor 4 (TLR4) polymorphisms with PCOS.

Materials and methods

A total of 219 women with PCOS and 272 healthy women were recruited in the study. Their samples were genotyped for the polymorphism of CD14 and TLR4 genes.

Results

The distributions of genotypes of both polymorphisms were found to be significant in women with PCOS compared with controls. The distributions of alleles were also found to be predominant in PCOS compared with controls.

Conclusion

Polymorphisms in CD14-159C>T and TLR4-299A>G significantly increased susceptibility to PCOS. Further studies with larger sample sizes are warranted to confirm these findings.

How to cite this article

Allauddin N, Rozati R. Single Nucleotide Polymorphisms in CD14 and Toll-like Receptor 4 Genes in Patients with Polycystic Ovarian Syndrome. J South Asian Feder Obst Gynae 2017;9(4):304-307.


HTML PDF Share
  1. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol (Oxf) 1989 Apr;30(4):459-470.
  2. New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv 2002 Nov;57(11):755-767.
  3. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006 Nov-Dec;12(6):673-683.
  4. Dyslipidemia with particular regard to apolipoprotein profile in association with polycystic ovary syndrome: a study among Indian women. Int J Fertil Womens Med 2001 Sep-Oct;46(5):271-277.
  5. Changes in 3 glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab 2005 Jun;90(6):3236-3242.
  6. Familial background of complex diseases in PCOS probands of South Indian population. Asian J Epidemiol 2012;5(2)50-55.
  7. The promoter –1031(T/C) polymorphism in tumor necrosis factor-alpha associated with polycystic ovary syndrome. Reprod Biol Endocrinol 2011 Oct;9:131.
  8. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril 2011 Mar;95(3):1048-1058.
  9. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev 2005 Apr;26(2):251-282.
  10. The -159C/T polymorphism in the CD14 gene and tuberculosis risk: a meta-analysis. Int J Med Sci 2013;10(11)1524-1529.
  11. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003 Oct;3(10):791-800.
  12. Toll-like receptor signaling. J Biol Chem 2003 Oct;278(40):38105-38108.
  13. Association of MIF-173 gene polymorphism with inflammatory bowel disease in Chinese Han population. Cytokine 2008 Jan;41(1):44-47.
  14. Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14. Clin Exp Immunol 2002 May;128(2):326-332.
  15. TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease. Eur J Human Gene 2004 Dec;12(12):1041-1049.
  16. Innate immunity genes as candidate genes: searching for relevant natural polymorphisms in databases and assessing family-based association of polymorphisms with human diseases. Methods Mol Biol 2008;415:17-48.
  17. , For the Genetic Factors in Neonatology Study Group. Polymorphisms of genes involved in innate immunity: association with preterm delivery. Mol Hum Reprod 2004 Dec;10(12):911-915.
  18. Presence of functional TLR2 and TLR4 on human adipocytes. Histochem Cell Biol 2007 Feb;127(2):131-137.
  19. Innate immunity and adipocyte function: ligand-specific activation of multiple toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes. Obesity (Silver Spring) 2009 Apr;17(4):648-656.
  20. A functional nonsynonymous toll-like receptor 4 gene polymorphism is associated with metabolic syndrome, surrogates of insulin resistance, and syndromes of lipid accumulation. Metabolism 2010 May;59(5):711-717.
  21. Genetics SNPs, silent but not invisible. Science 2007 Jan;315(5811):466-467.
  22. Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet 2011 Aug;12(10):683-691.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.